View Author
scopus: 8348880900

Leeuwen, P.J. van

(Pim van Leeuwen)


cancer screening prostate mortality prostate cancer study death biopsy patient control erspc trial population group result diagnosis number interval control arm level incidence cause european randomized study randomized treatment disease intervention rotterdam effect european table detection volume score analysis follow-up difference gleason value antigen reduction survival outcome tumour intervention arm round serum stage psa testing roobol netherland prostate cancer screening mortality rate urology chapter screening arm mortality rates screen tumor roobol mj schroder fh testing baseline tumour volume figure prostate cancer mortality cohort screening round van leeuwen pj schroder increase study entry prostatectomy psa levels leeuwen psa level prostate cancer incidence pca mortality benefit method




10 Most Recent Publications

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: Consequences for cancer incidence, overall mortality and cancer-specific mortality (Article)
Zhu, X.D. Leeuwen, P.J. van Holmberg, E. Bul, M. Carlsson, S. Schröder, F.H. Roobol, M.J. Hugosson, J.
2012-09-01
Prostate Cancer Screening : The effect on prostate cancer mortality and incidence (Doctoral Thesis)
Leeuwen, P.J. van
2012-05-16
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy (Article)
Wolters, T. Montironi, R. Kwast, Th.H. van der Mazzucchelli, R. Scarpelli, M. Roobol, M.J. Bergh, R.C.N. van den Leeuwen, P.J. van Hoedemaeker, R.F. Leenders, G.J. van Schröder, F.H.
2012-01-01
Towards an optimal interval for prostate cancer screening (Article)
Leeuwen, P.J. van Roobol, M.J. Kranse, R. Zappa, M. Carlsson, S. Bul, M. Zhu, X.D. Bangma, C.H. Schröder, F.H. Hugosson, J.
2012-01-01
Re: Disease-specific survival of men with prostate cancer detected during the screening interval: Results of the european randomized study of screening for prostate cancerrotterdam after 11 years of follow-up (Article)
Zhu, X. Leeuwen, P.J. van Bul, M. Otto, S.J. Koning, H.J. de Bangma, C.H. Schröder, F.H. Roobol, M.J.
2011-11-01
Disease-specific survival of men with prostate cancer detected during the screening interval: Results of the European Randomized Study of Screening for Prostate Cancer-Rotterdam after 11 years of follow-up (Article)
Zhu, X.D. Leeuwen, P.J. van Bul, M. Otto, S.J. Koning, H.J. de Bangma, C.H. Schröder, F.H. Roobol, M.J.
2011-08-01
Disease-specific survival of men with prostate cancer detected during the screening interval: Results of the European Randomized Study of Screening for Prostate Cancer-Rotterdam after 11 years of follow-up (Article)
Zhu, X.D. Leeuwen, P.J. van Bul, M. Otto, S.J. Koning, H.J. de Bangma, C.H. Schröder, F.H. Roobol, M.J.
2011-08-01
Reply to balancing the harms and benefits of early detection of prostate cancer (Article)
Leeuwen, P.J. van Connolly, D.
2011-08-01
Prostate cancer screening has no effect on prostate cancer specific mortality over 20 years of follow-up of Swedish men (Article)
Leeuwen, P.J. van
2011-07-06
Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam) (Article)
Zhu, X.D. Leeuwen, P.J. van Bul, M. Bangma, C.H. Roobol, M.J. Schröder, F.H.
2011-04-06